GWAS |
- A body shape index ( 34021172)
- Age-related cognitive decline (language) (slope of z-scores) ( 30954325)
- Biochemical measures ( 19260141)
- Cardiac hypertrophy ( 21348951)
- Cerebral amyloid angiopathy x APOEe4 status interaction in Alzheimer’s disease ( 34020725)
- Emphysema imaging phenotypes ( 26030696)
- Heart rate response to recovery post exercise (20 sec) ( 29497042)
- Longevity (90 years and older) ( 25199915)
- Obesity-related traits ( 23251661)
- Obsessive-compulsive disorder ( 22889921)
- Palmitic acid (16:0) levels ( 23362303)
- Pursuit maintenance gain ( 29064472)
- Renal function-related traits (eGRFcrea) ( 22797727)
- Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder ( 33824429)
- Waist circumference adjusted for body mass index ( 34021172)
- Weight ( 28552196)
|
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885)
- Body mass index ( 22446040)
- Breast cancer ( 17903305)
- Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes ( 29221444)
- Forehead morphology ( 29921221)
- Generalized epilepsy ( 30531953)
- Glucocorticoid-induced osteonecrosis ( 26265699)
- HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction ( 31806883)
- Hepatocellular carcinoma ( 22807686)
- Hyperactive-impulsive symptoms ( 18821565)
- Lung cancer ( 34062886)
- Periodontitis (DPAL) ( 24024966)
- Plasma parathyroid hormone levels ( 30134803)
- Refractive error ( 32231278)
- Response to statin therapy ( 20339536)
- Spherical equivalent or myopia (age of diagnosis) ( 29808027)
|